Evaluating Long Term Efficacy of ESWT on Symptomatic Improvement of Patients with Chronic Pelvic Pain Syndrom in Thi-Qar

  • Ali Abdulbaqi Ali IsnineI Assist. Prof, F1.C M.S Urology, Department of Surgery, Thi-Qar medical college, University of Thi-Qar, Iraq,
  • Harith Adel Jasim F1.C M.S Urology, department of urology, ThiQar Health Directorate
  • Hussein Ali Hamad
Keywords: CPPS, non-bacterial prostatitis, ESWT, long-term, treatment

Abstract

The CPPS is nearly the commonest controversial topic in urology with the emerge of a new modality of management by shockwave therapy. The aim of the study to assess the long term efficacy of CPPS treatment by ESWT, where patients with non-bacterial type prostatitis.  The study was conducted on 120 CPPS patients where they were randomly dispersed into the  sham and treatment groups and evaluated at 8th, 24th, lastly on 36th  weeks. A treatment group of patients was managed by  ESWT  once a week for 6 weeks using LUBIS-ONE (mode A, level 5/5-10min.). While the second group (sham group), there was an application of the same protocol without firing probe. The pain visual analog scale was used for follow-up assessments. Patient Global Impression of Improvement (PGI-I) and "National Institutes of Health-developed Chronic Prostatitis Symptom Index" (NIH-CPSI). independent t-test was used for data comparison and analysis of variances. In this study, nine patients only cannot complete the protocol of the study, hundred eleven patients were evaluated (fifty-seven patients as a treatment group, while sham group was 54 patients). At the 24th  week of follow-up, the mean urinary score, pain score, NIH-CPSI score and between quality-of-life two groups were of non-significant statistical difference. While, ESWT therapy has been established as a non-invasive effective mode of therapy in CPPS in following-up for short-term, long-term efficacy was not supported by this study.

References

Balvocius A. Chronic prostatitis with chronic pelvic pain syndrome. Medicina (Kaunas) 2002;38(Suppl 1):36–41. [PubMed] [Google Scholar]

Badalyan RR, Fanarjyan SV, Aghajanyan IG. Chlamydial and ureaplasmal infections in illess with nonbacterial chronic prostatitis. Andrologia. 2003;35:263–5. [PubMed] [Google Scholar]

Krieger JN, Jacobs RR, Ross SO. Does the chronic prostatitis/pelvic pain syndrome differ from nonbacterial prostatitis and prostatodynia? J Urol. 2000;164:1554–8. [PubMed] [Google Scholar]

Hochreiter W, Bader P. Etiopathogenesis of prostatitis. Urologe A. 2001;40:4–8. [PubMed] [Google Scholar]

Delavierre D, Rigaud J, Sibert L, Labat JJ. Symptomatic approach to chronic prostatitis/chronic pelvic pain syndrome. Prog Urol. 2010;20:940–53. [PubMed] [Google Scholar]

Donovan DA, Nicholas PK. Prostatitis: Diagnosis and dealing in primary care. Nurse Pract. 1997;22:144–6. 149. [PubMed] [Google Scholar]

Gonzalez RR, Te AE. Is there a role for urodynamics in chronic nonbacterial prostatitis? Curr Urol Rep. 2006;7:335–8. [PubMed] [Google Scholar]

Lenk S. Diagnosis of chronic prostatitis. Urologe A. 2001;40:9–11. [PubMed] [Google Scholar]

Forrest JB, Nickel JC, Moldwin RM. Chronic prostatitis/chronic pelvic pain syndrome and male interstitial cystitis: Enigmas and opportunities. Urology. 2007;69:60–3. [PubMed] [Google Scholar]

Schaeffer AJ. Etiology and management of chronic pelvic pain syndrome in men. Urology. 2004;63(3 Suppl 1):75–84. [PubMed] [Google Scholar]

Lv C, Zhong Z, Wu Z, Xiao N, Yang M, Zhao X. Nonbacterial prostatitis in Kunming mouse induced by long-term stimuli of passive sexual abstinence. J Androl. 2010;31:244–9. [PubMed] [Google Scholar]

Schaeffer AJ, Datta NS, Fowler JE, Jr, Krieger JN, Litwin MS, Nadler RB, et al. Overview summary statement. Diagnosis and management of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) Urology. 2002;60:1–4. [PubMed] [Google Scholar]

Krhen I, Skerk V, Schönwald S, Mareković Z. Classification, diagnosis and dealing of prostatitis syndrome. Lijec Vjesn. 2002;124:89–98. [PubMed] [Google Scholar]

Lipsky BA. Prostatitis and urinary tract infection in men: What's new; what's true? Am J Med. 1999;106:327–34. [PubMed] [Google Scholar]

Kunishima Y, Takeyama K, Takahashi S, Matsukawa M, Koroku M, Tanda H, et al. Gatifloxacin dealing for chronic prostatitis: A prospective multicenter clinical trial. J Infect Chemother. 2008;14:137–40. [PubMed] [Google Scholar]

Chuang YC, Chancellor MB. The application of botulinum toxin in the prostate. J Urol. 2006;176 (6 Pt 1):2375–82. [PubMed] [Google Scholar]

Datta NS. Role of alpha-blockers in the dealing of chronic prostatitis. Urology. 2002;60(6 Suppl):27–8. [PubMed] [Google Scholar]

Kulovac B, Aganović D, Prcić A, Hadziosmanović O. Management of chronic nonbacterial prostatitis/chronic pelvic pain syndrome. Bosn J Basic Med Sci. 2007;7:245–9. [PMC free article] [PubMed] [Google Scholar]

Holm M, Meyhoff HH. Chronic prostatic pain. A new dealing option with finasteride? Scand J Urol Nephrol. 1997;31:213–5. [PubMed] [Google Scholar]

Nickel JC, Downey J, Pontari MA, Shoskes DA, Zeitlin SI. A randomized placebo-controlled multicentre study to evaluate the safety and efficacy of finasteride for male chronic pelvic pain syndrome (category IIIA chronic nonbacterial prostatitis) BJU Int. 2004;93:991–5. [PubMed] [Google Scholar]

Liatsikos EN, Dinlenc CZ, Kapoor R, Smith AD. Transurethral microwave thermotherapy for the dealing of prostatitis. J Endourol. 2000;14:689–92. [PubMed] [Google Scholar]

Mené MP, Ginsberg PC, Finkelstein LH, Manfrey SJ, Belkoff L, Ogbolu F, et al. Transurethral microwave hyperthermia in the dealing of chronic nonbacterial prostatitis. J Am Osteopath Assoc. 1997;97:25–30. [PubMed] [Google Scholar]

Marx S, Cimniak U, Beckert R, Schwerla F, Resch KL. Chronic prostatitis/chronic pelvic pain syndrome. Influence of osteopathic dealing-a randomized controlled study. Urologe A. 2009;48:1339–45. [PubMed] [Google Scholar]

Posadzki P, Zhang J, Lee MS, Ernst E. Acupuncture for chronic nonbacterial prostatitis/chronic pelvic pain syndrome: A systematic review. J Androl. 2012;33:15–21. [PubMed] [Google Scholar]

Potts JM. Nonpharmacological approaches for the dealing of urological chronic pelvic pain syndromes in men. Curr Urol Rep. 2009;10:289–94. [PubMed] [Google Scholar]

Yan X, Yang G, Cheng L, Chen M, Cheng X, Chai Y, et al. Effect of extracorporeal shock wave therapy on diabetic chronic wound healing and its histological features. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2012;26:961–7. [PubMed] [Google Scholar]

Qin X, Lu YP. Application of extracorporeal shockwave therapy in andrology. Zhonghua Nan Ke Xue. 2012;18:1125–9. [PubMed] [Google Scholar]

Zeng XY, Liang C, Ye ZQ. Extracorporeal shock wave dealing for non-inflammatory chronic pelvic pain syndrome: A prospective, randomized and sham-controlled study. Chin Med J (Engl) 2012;125:114–8. [PubMed] [Google Scholar]

Zimmermann R, Cumpanas A, Hoeltl L, Janetschek G, Stenzl A, Miclea F. Extracorporeal shock-wave therapy for treating chronic pelvic pain syndrome: A feasibility study and the first clinical outcomes. BJU Int. 2008;102:976–80. [PubMed] [Google Scholar]

Zimmermann R, Cumpanas A, Miclea F, Janetschek G. Extracorporeal shock wave therapy for the dealing of chronic pelvic pain syndrome in males: A randomised, double-blind, placebo-controlled study. Eur Urol. 2009;56:418–24. [PubMed] [Google Scholar]

Vahdatpour B, Alizadeh F, Moayednia A, Emadi M, Khorami MH, Haghdani S. Efficacy of extracorporeal shock wave therapy for the dealing of chronic pelvic pain syndrome: A randomized, controlled trial. ISRN Urol. 2013;2013:972601. [PMC free article] [PubMed] [Google Scholar]

Huskisson EC. Measurement of pain. Lancet. 1974;2:1127–31. [PubMed] [Google Scholar]

Litwin MS, McNaughton-Collins M, Fowler FJ, Jr, Nickel JC, Calhoun EA, Pontari MA, et al. The National Institutes of Health Chronic Prostatitis Symptom Index: Development and validation of a new outcome measure. Chronic Prostatitis Collaborative Research Network. J Urol. 1999;162:369–75. [PubMed] [Google Scholar

Published
2021-02-27
Section
Articles